Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

873

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate Cancer Recurrent
Prostate Cancer Metastatic
Metastatic Cancer
Oligometastatic Disease
Oligometastasis
Hormone Sensitive Prostate Cancer

Interventions

OTHER: Radiotherapy (SBRT) and/or surgery (metastasectomy)
DRUG: Androgen deprivation therapy
DRUG: Androgen receptor targeted therapy

Sponsor

Universitaire Ziekenhuizen KU Leuven